Sphera Funds Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $9.37M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $22.4M | Buy |
|
|||||
|
2019
Q4 | $12.5M | Sell |
|
|||||
|
2019
Q3 | $16.2M | Sell |
|
|||||
|
2019
Q2 | $44.1M | Buy |
|
|||||
|
2019
Q1 | $33.4M | Buy |
|
|||||
|
2018
Q4 | $16.4M | Buy |
|
|||||
|
2018
Q3 | $19.7M | Sell |
|
|||||
|
2018
Q2 | $19.9M | Buy |
|
|||||
|
2018
Q1 | $9.14M | Sell |
|
|||||
|
2017
Q4 | $14.4M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $12.2M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $13.8M | Buy |
|
|||||
|
2016
Q3 | $8.58M | Buy |
|
|||||
|
2016
Q2 | $4.94M | Buy |
|
|||||
|
2016
Q1 | $5.57M | Sell |
|
|||||
|
2015
Q4 | $11.3M | Buy |
|
|||||
|
2015
Q3 | $5.47M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $4.33M | Buy |
|